ORC
O'Rourke & Company Portfolio holdings
AUM
$214M
This Quarter Return
-4.36%
1 Year Return
+16.05%
3 Year Return
+59.61%
5 Year Return
–
10 Year Return
–
AUM
$145M
AUM Growth
+$145M
(-3.2%)
Cap. Flow
+$2.56M
Cap. Flow
% of AUM
1.76%
Top 10 Holdings %
Top 10 Hldgs %
42.48%
Holding
127
New
8
Increased
74
Reduced
32
Closed
5
Top Buys
| 1 |
Apollo Global Management
APO
|
$1.7M |
| 2 |
VanEck Preferred Securities ex Financials ETF
PFXF
|
$1.61M |
| 3 |
Analog Devices
ADI
|
$387K |
| 4 |
Vanguard Small-Cap Value ETF
VBR
|
$355K |
| 5 |
Vanguard Energy ETF
VDE
|
$305K |
Top Sells
| 1 |
Invesco Preferred ETF
PGX
|
$1.71M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$556K |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$387K |
| 4 |
iShares Global 100 ETF
IOO
|
$246K |
| 5 |
General Motors
GM
|
$245K |
Sector Composition
| 1 | Financials | 15.55% |
| 2 | Technology | 15.15% |
| 3 | Healthcare | 6.21% |
| 4 | Communication Services | 4.05% |
| 5 | Consumer Discretionary | 3.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Berkshire Hathaway Class B
BRK.B
$1.08T
| $1.44M | 0.99% |
4,068
+110
| +3% | +$38.8K |
|
27
SPDR Bloomberg Convertible Securities ETF
CWB
$4.38B
| $1.39M | 0.96% |
18,012
+962
| +6% | +$74K |
|
28
Welltower
WELL
$112B
| $1.36M | 0.94% |
14,169
-834
| -6% | -$80.2K |
|
29
GSK
GSK
$77.9B
| $1.24M | 0.85% |
28,435
+2,075
| +8% | +$90.4K |
|
30
JPMorgan Equity Premium Income ETF
JEPI
$40.8B
| $1.24M | 0.85% |
20,153
+4,737
| +31% | +$291K |
|
31
IBM
IBM
$223B
| $1.19M | 0.82% |
9,172
-200
| -2% | -$26K |
|
32
Verizon
VZ
$185B
| $1.19M | 0.82% |
23,364
-64
| -0.3% | -$3.26K |
|
33
Coca-Cola
KO
$296B
| $1.14M | 0.78% |
18,357
+618
| +3% | +$38.3K |
|
34
Bristol-Myers Squibb
BMY
$96.1B
| $1.1M | 0.76% |
15,085
-3,200
| -18% | -$234K |
|
35
Invesco Water Resources ETF
PHO
$2.24B
| $1.08M | 0.74% |
20,303
-839
| -4% | -$44.5K |
|
36
Vanguard Small-Cap ETF
VB
$65.6B
| $1.03M | 0.71% |
4,856
+2
| +0% | +$425 |
|
37
Pfizer
PFE
$141B
| $1.03M | 0.71% |
19,895
+511
| +3% | +$26.5K |
|
38
iShares Biotechnology ETF
IBB
$5.65B
| $1M | 0.69% |
7,698
-1,004
| -12% | -$131K |
|
39
Vanguard Total International Stock ETF
VXUS
$101B
| $991K | 0.68% |
16,580
+612
| +4% | +$36.6K |
|
40
SPDR S&P 500 ETF Trust
SPY
$649B
| $979K | 0.67% |
2,168
+233
| +12% | +$105K |
|
41
Vanguard Mid-Cap ETF
VO
$86.4B
| $920K | 0.63% |
3,870
+75
| +2% | +$17.8K |
|
42
Procter & Gamble
PG
$371B
| $878K | 0.6% |
5,748
+201
| +4% | +$30.7K |
|
43
Eastern Bankshares
EBC
$3.35B
| $876K | 0.6% |
40,684
+170
| +0.4% | +$3.66K |
|
44
iShares Select Dividend ETF
DVY
$20.6B
| $863K | 0.59% |
6,733
+121
| +2% | +$15.5K |
|
45
First Trust Capital Strength ETF
FTCS
$8.44B
| $843K | 0.58% |
10,785
-370
| -3% | -$28.9K |
|
46
Goldman Sachs
GS
$220B
| $767K | 0.53% |
2,324
+17
| +0.7% | +$5.61K |
|
47
Carlyle Group
CG
$23B
| $757K | 0.52% |
15,472
+11
| +0.1% | +$538 |
|
48
Health Care Select Sector SPDR Fund
XLV
$33.8B
| $727K | 0.5% |
5,307
+77
| +1% | +$10.5K |
|
49
Vanguard S&P Mid-Cap 400 ETF
IVOO
$2.76B
| $716K | 0.49% |
3,938
+292
| +8% | +$53.1K |
|
50
Vanguard Dividend Appreciation ETF
VIG
$94.5B
| $712K | 0.49% |
4,390
+783
| +22% | +$127K |
|